Pursuant to the provision of Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, Syncom Healthcare has submitted a Statement on Investor Complaints for the quarter ended 31st March 2017.
The above information is a part of company’s filings submitted to BSE.